An expert advises a few things to keep in mind when patients with cancer are navigating these platforms.
CURE Winter 2024
At CURE, we remain steadfastly dedicated to providing our readers with answers about cancer research.
Since 2000, antibody-drug conjugates have been approved by the Food and Drug Administration for various cancer types, such as breast cancer.
With more than 150 treatments being studied in clinical trials, what is on the horizon for antibody-drug conjugates in breast cancer?
Advertisement
Advertisement
Trending on CURE
1
Understanding Stage 2 Kidney Cancer (Renal Cell Carcinoma)
2
FDA Grants Orphan Drug Designation to AMXT 1501 With DFMO in Neuroblastoma
3
Reclaiming Intimacy for Women After Cancer
4
A Cancer Portrait Hidden in the Attic of My Mind
5
